APPLICATION DEADLINE EXTENDED: NOVEMBER 19, 2024
APPLY TODAY
DOWNLOAD THE BROCHURE
About the Course
ASENT is pleased to offer a 2-day course March 10-11, 2025 at the Hyatt Regency Bethesda, in Bethesda, MD to introduce researchers and clinicians to the principles of neurotherapeutic clinical trial development and implementation. The course will be especially relevant if you are interested in conducting neurotherapeutic clinical trials.
The course covers the principles of clinical trials from pre-clinical programs to Phase III design and implementation, including necessary regulatory conversations and IND enabling studies, IRB oversight and adverse event tracking and reporting. The course considers clinical trials in the neurotherapeutic space for both drugs and devices. The course will also address the unique challenges inherent in developing treatments for nervous system disorders.
The course will feature a mix of:
Didactic sessions that go in depth into a wide range of topics
Interactive workshops where participants will work in teams on projects such as drafting protocols and addressing adverse events
Panel discussions with lively Q&A
Discounted access to the ASENT Annual Meeting
Participants who attend the course will have ongoing access to senior faculty in attendance in a mentoring capacity. We anticipate that most applicants will have some familiarity with clinical research however, any clinical investigator who would benefit from the course is invited to apply. Those in industry and in private practice are also welcome to apply. The course will be offered annually and participants have discounted access to the ASENT Annual Meeting.
You will be asked to provide:
We are excited to have the opportunity to offer this course, which we believe will help to advance the availability of new drugs for patients with neurological conditions. If your work would benefit from an understanding of neurologic clinical trials you are encouraged to apply.
